title: Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease.
abstract: Besides various gastroduodenal diseases, Helicobacter pylori infection may be involved in autoimmune disorders like rheumatoid arthritis (RA) or idiopathic thrombocytopenic purpura. Such autoimmune disorders are often associated with autoreactive antibodies produced by B-1 cells, a subpopulation of B lymphocytes. These B-1 cells are mainly located in the pleural cavity or mucosal compartment. The existence of H. pylori urease-specific immunoglobulin A (IgA)-producing B cells in the mucosal compartment and of their specific IgM in the sera of acutely infected volunteers suggests the possibility that urease stimulates mucosal innate immune responses. Here, we show for the first time that purified H. pylori urease predominantly stimulates the B-1-cell population rather than B-2 cells, which produce antigen-specific conventional antibodies among splenic B220(+) B cells. The fact that such stimulation of B-1 cells was not affected by the addition of polymyxin B indicates that the effect of purified H. pylori urease was not due to the contamination with bacterial lipopolysaccharide. Furthermore, the production of various B-1-cell-related autoreactive antibodies such as IgM-type rheumatoid factor, anti-single-stranded DNA antibody, and anti-phosphatidyl choline antibody was observed when the splenic B cells were stimulated with purified H. pylori urease in vitro. These findings suggest that H. pylori components, urease in particular, may be among the environmental triggers that initiate various autoimmune diseases via producing autoreactive antibodies through the activation of B-1 cells. The findings shown here offer important new insights into the pathogenesis of autoimmune disorders related to H. pylori infection.
authors.affiliation: Department of Microbiology and Immunology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan. htkuhkai@nms.ac.jp
authors.forename: Shingo
authors.initials: S
authors.lastname: Yamanishi
authors.forename: Tadasu
authors.initials: T
authors.lastname: Iizumi
authors.forename: Eri
authors.initials: E
authors.lastname: Watanabe
authors.forename: Masumi
authors.initials: M
authors.lastname: Shimizu
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kamiya
authors.forename: Kumiko
authors.initials: K
authors.lastname: Nagata
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kumagai
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Fukunaga
authors.forename: Hidemi
authors.initials: H
authors.lastname: Takahashi
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000096:biosynthesis*; D001327:Autoimmune Diseases / Q000201:enzymology / Q000276:immunology / Q000382:microbiology; D001402:B-Lymphocytes / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D049109:Cell Proliferation; D005260:Female; D016480:Helicobacter pylori / Q000201:enzymology* / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D014510:Urease / Q000302:isolation & purification / Q000502:physiology*
chemical_list: D001323:Autoantibodies; D014510:Urease